Top 6 manufacturers in Ovarian Cancer Treatment Drugs Market
By Prof Researh
Updated 11:00:19 November 30, 2019
.
Updated 11:00:19 November 30, 2019
Prof Resear published a new Market report on Ovarian Cancer Treatment Drugs Market. It present the largest 6 manufacruers in Ovarian Cancer Treatment Drugs Market. The report is a professional and in-depth study on the current state of the global Ovarian Cancer Treatment Drugs market with a focus on the Chinese market. The report provides key statistics on market of Ovarian Cancer Treatment Drugs. It is a valuable source of guidance and direction for companies and individuals interested in Ovarian Cancer Treatment Drugs industry.
.
AstraZeneca
Ref A: BF1BE61A083F443C8296B0830D19903E Ref B: SJCEDGE0208 Ref C: 2019-11-30T03:00:04Z
Roche
Ref A: 1704466C078A48C2A35A3F506B219FE0 Ref B: SJCEDGE0416 Ref C: 2019-11-30T03:00:06Z
Tesaro
Employees at TESARO, Inc. TESARO—an oncology-focused business within GSK dedicated to improving the lives of people impacted by cancer. Learn about our products, our approach to science, and our commitment to care. See the company profile for TESARO , Inc. (TSRO ) including business summary, industry/sector information, number of employees, business summary, corporate governance, key executives and their ...
Clovis Oncology
Founded in 2009, Clovis Oncology (NASDAQ: CLVS ) is a commercial stage biotechnology company focused on acquiring, developing and commercializing cancer treatments in the United States, Europe and other international markets. Nov 10, 2019 · Clovis Oncology , Inc . is a commercial stage biotechnology company, which engages in the acquisition, development, and commercialization of cancer treatments in the United States, Europe, and other... Clovis Oncology , Inc . is a biopharmaceutical company focused on acquiring, developing and commercializing anti-cancer agents in the United States, Europe and other international markets.
Kazia Therapeutics
Ref A: DD77EBB8838F48FD87A4EE44212F1D17 Ref B: SJCEDGE0408 Ref C: 2019-11-30T03:00:15Z
Polaris Pharma
Ref A: 76D1BA7B1ACF4A169C34BD254DE80EF9 Ref B: SJCEDGE0419 Ref C: 2019-11-30T03:00:19Z